Targeting of human and mouse T-lymphocytes by monoclonal antibody-HPMA copolymer–doxorubicin conjugates directed against different T-cell surface antigens
- 31 March 1998
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 52 (3) , 253-270
- https://doi.org/10.1016/s0168-3659(97)00210-1
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Cytotoxic and cytostatic effects of anti-Thy 1.2 targeted doxorubicin and cyclosporin AJournal of Controlled Release, 1996
- Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responsesEuropean Journal of Immunology, 1995
- Targetable photoactivalable drugs. 3. In vitro efficacy of polymer bound chlorin e6 toward human hepatocarcinoma cell line (PLC/PRF/5) targeted with galactosamine and to mouse splenocytes targeted with anti-Thy 1.2 antibodiesJournal of Controlled Release, 1993
- Antibody-targeted cyclosporin AJournal of Controlled Release, 1992
- Targetable Polymeric Anticancer DrugsAnnals of the New York Academy of Sciences, 1991
- Antigen density on target cells determines the immunosuppressive potential of rat IgG2b monoclonal antibodiesEuropean Journal of Immunology, 1989
- Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125i]daunomycinJournal of Controlled Release, 1989
- Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyClinical Immunology and Immunopathology, 1988
- Evaluation of ricin A-chain immunotoxins directed against human T cellsCellular Immunology, 1986
- Epidermal growth factor-toxin A chain conjugates: EGF-Ricin A is a potent toxin while EGF-diphtheria fragment A is nontoxicCell, 1980